Georgetown University
- Country
- 🇬🇹Guatemala
- Ownership
- Private
- Established
- 1789-01-23
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.georgetown.edu
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer
- Conditions
- Ovarian Cancer
- First Posted Date
- 2004-07-08
- Last Posted Date
- 2011-03-24
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 50
- Registration Number
- NCT00003297
- Locations
- 🇺🇸
Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington, District of Columbia, United States
VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-05-25
- Last Posted Date
- 2011-03-24
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 45
- Registration Number
- NCT00004030
- Locations
- 🇺🇸
Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington, District of Columbia, United States
Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors
- Conditions
- Esophageal CancerPancreatic CancerUnspecified Adult Solid Tumor, Protocol SpecificGastric CancerLung CancerBreast Cancer
- First Posted Date
- 2004-04-14
- Last Posted Date
- 2011-03-24
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 24
- Registration Number
- NCT00003125
- Locations
- 🇺🇸
Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, United States
🇺🇸National Naval Medical Center, Bethesda, Maryland, United States
Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2004-02-19
- Last Posted Date
- 2011-03-24
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 40
- Registration Number
- NCT00003035
- Locations
- 🇺🇸
Lombardi Cancer Center, Washington, District of Columbia, United States
Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer
- Conditions
- Breast Neoplasms
- Interventions
- First Posted Date
- 2003-11-17
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 46
- Registration Number
- NCT00073073
- Locations
- 🇺🇸
Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, United States
🇺🇸National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-03-24
- Lead Sponsor
- Georgetown University
- Registration Number
- NCT00020748
- Locations
- 🇺🇸
Lombardi Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States
Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis
- Conditions
- End Stage Renal DiseaseHyperhomocysteinemia
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 84
- Registration Number
- NCT00004495
- Locations
- 🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States